ETFs SynAct Pharma AB

SYNACT

SE0008241491

Pharmaceuticals

Market Closed - Nasdaq Stockholm 12:00:00 2026-08-24 EDT			5-day change	1st Jan Change
19.00 ^SEK	-4.23%		-3.94%	-15.93%

08-20	SynAct Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Synact Pharma reports narrower operating loss	FW

ETFs positioned on SynAct Pharma AB

Name		YTD change	Weight	AuM
STATE STREET SPDR PORTFOLIO EUROPE ETF - USD		+9.91%	0%	742 M€

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Employees

Sector

Pharmaceuticals

Calendar

11-01 Earnings release - Q3 2026

More about the company